glp-1 connecticut exposure calls to Poison Control triple over 2 years GLP-1 Medications for Weight Loss
Description
The company is involved in diabetes treatment through GLP-1 receptor agonists and combination therapies

[DOI] [PMC free article] [PubMed] [Google Scholar] 77.Zhang D., Fu M., Gao S.-H., Liu J.-L
Abstract The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the management of hyperglycaemia in type 2 diabetes in adults, published since 2006 and last updated in 2019

Participants in both trials were randomized in a 1:1 ratio to receive the maximum tolerated weekly dose of tirzepatide (10 mg or 15 mg) or placebo for 52 weeks

Is it safe with diabetes or high blood pressure

In keeping with current guidelines, it is recommended that patients are reassessed within 23 months of switching to assess the adequacy of dose titration, side effects, need for adjustment of other medications, and achievement of therapeutic goals (4)
